After previous disappointments with BTK inhibitors, a novel drug in this class is the first to show superiority to an active ...
Natalizumab demonstrates sustained long-term safety and efficacy for treating relapsing-remitting multiple sclerosis through 15 years of follow-up.
The final four teams in the 2026 ACC baseball tournament battled it out Saturday for a spot in Sunday's tournament final. Top-seeded Georgia Tech started off with a one-sided victory over No. 5 Miami ...
The SCORE Act, a landmark piece of legislation that would pave the way for new standards in college sports on matters including revenue sharing and athlete compensation, will not be brought to the ...
Congress' attempts to fix college sports hit another roadblock. The SCORE Act, which was set to be voted on this week in the House of Representatives, was pulled, per a Yahoo! Sports report. This ...
For decades, the IQ test has been one of the most familiar — and most contested — yardsticks for human intelligence. Now, a startup project called AI IQ is applying the same metaphor to artificial ...
Caitlin Clark shined as the Indiana Fever won their first game of the 2026 WNBA season, taking down Cameron Brink and the Los Angeles Sparks by the final score of 87-78 on Wednesday night. Clark ...
Positive pre-BLA meeting with FDA alignment reached on KYSA-8 single-arm trial in stiff person syndrome (SPS); rolling BLA submission initiated Miv-cel pivotal trial primary analysis results in SPS de ...
Positive pre-BLA meeting with FDA alignment reached on KYSA-8 single-arm trial in stiff person syndrome (SPS); rolling BLA submission ...
American math and reading test scores have fallen in the last decade, according to data released Wednesday by the Educational Opportunity Project at Stanford. Read more about why that’s happening.
The drops go beyond the pandemic and cut across income, geographic and racial divides, new data shows. By Claire Cain Miller Francesca Paris and Sarah Mervosh Something troubling is happening in U.S.
Purpose Multiple sclerosis (MS) is a chronic neurological condition that affects approximately 150 000 people in the UK and presents a significant healthcare burden, including the high costs of ...